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Abstract
Objective Milk can reduce intestinal tissue damage in colitis models, and protects infants against necrotizing enteroco-
litis. However, whether milk can decrease inflammation related to peri-implantitis and oral mucosal dehiscence remains
unclear. We therefore investigated whether or not milk and fermented by-products have any anti-inflammatory effects on
the cells of the oral cavity.
Material and methods Human gingival fibroblasts and the human oral epithelial cell line HSC2 were exposed to pasteurized
human milk, pasteurized cow’s milk, dairy products, and powderedmilk. An inflammatory response was then provoked with IL1
and TNFα. The expression changes of IL1, IL6, and IL8 were detected by reverse transcriptase PCR and immunoassay.
Results We can report that pasteurized human milk and pasteurized cow’s milk as well as yoghurt, buttermilk, sour milk,
whey, and powdered milk can lower the expression of inflammatory cytokines in gingival fibroblasts being stimulated
by IL1 and TNFα. A similar anti-inflammatory response to pasteurized milk and dairy products was observed with the
human oral epithelial cell line HSC2.
Conclusion These data suggest that pasteurized and powdered milk, as well as fermented dairy products, display an anti-
inflammatory effect on oral fibroblasts and oral epithelial cells.
Clinical relevance Our in vitro findings provide the scientific basis to extend this research towards testing the anti-inflammatory
effects of milk in a pre-clinical periodontitis and peri-implantitis model.
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Introduction
Milk is produced by the mammary gland, and contains nutri-
tional components for the growth and development of infants.
Milk can reduce inflammation of the intestine, for example,
necrotizing enterocolitis [1, 2]. Both human milk and cow’s
milk lower tissue injury and even mortality in chemically in-
duced endotoxemia models [3]. Further support for the anti-
inflammatory activity of milk is based on in vitro studies. For
example, pre-term human milk suppresses TNFα-induced in-
flammation in intestinal epithelial cells [4], while casein hy-
drolysate and its peptide-enriched fractions reduce the inflam-
matory response in Caco-2 cells and porcine colonic explants
[5]. Whey protein hydrolysates decrease IL8 secretion in
LPS-stimulated respiratory epithelial cells [6]. However, it is
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unknown if the anti-inflammatory effect of milk is indepen-
dent of the target cells. If this is so, it is reasonable to suggest
that milk exerts its anti-inflammatory effect in models
representing inflammation of the oral cavity.
Fermentation causes the denaturation of casein, and chang-
es the rheological properties of yoghurt, sour milk, and but-
termilk [7]. Pasteurization usually occurs at approximately
72 °C for 15 s [8] and for the preparation of yoghurt, milk is
heated to 80 °C to 95 °C for 10 to 30 min [9, 10]. Powdered
milk is heated to 160 °C or higher [11]. On the other hand, for
the production of cheese, casein is cleaved by rennet extract,
or by enzymes derived from plants, fungi, and microbial
sources [12]. What remains from milk after coagulation are
the whey serum proteins. Whey attenuates inflammation-
induced intestinal injury by improving mucosal barrier func-
tion [13]. Yoghurt has an anti-inflammatory activity in
humans with inflammatory bowel disease, and in experimen-
tally induced inflammatory bowel disease in mice. [14, 15]
Yoghurt can also prevent Candida albicans-induced mucosal
inflammation and proliferation in the forestomach of diabetic
rats [16]. The question arises as to whether powderedmilk and
fermented milk products induce an anti-inflammatory re-
sponse in oral cells?
Gingival fibroblast and oral epithelial cells are suitable
to use for in vitro models to study the possible anti-
inflammatory role of milk and its fermented products
[17, 18]. With this bioassay, these cells were exposed
to aqueous fractions of cow’s milk and human milk, as
well as fermented milk products with and without IL1
and TNFα. Usually, the cells responded with an in-
creased production of cytokines including IL1, IL6, and
IL8. The question arises as to whether this inflammatory
response can be attenuated by aqueous fractions of milk,
fermented milk products, and powdered milk. The aim of
the present study was to determine the anti-inflammatory
role of milk and milk products, with bioassays relevant
for oral health, particularly oral mucositis in patients
suffering from radiation [19], chemotherapy [20], and
chronic inflammatory disorders such as Crohn’s disease
[21], periodontitis, and peri-implantitis.
Material and methods
Human milk, cow’s milk, fermented milk products,
and cells
Human milk samples were collected at the Department of
Paediatrics and Adolescent Medicine, Division of
Neonatology, of the Medical University of Vienna.
Mother’s milk was prepared in daily totals for premature
babies and delivered to the feeding stations. Three left-
over residual amounts, which had been thawed and could
not be refrozen, were used for the present study. No
mother donated the milk for the study purpose by prima-
ry intension (Ethical Committee of the Medical
University of Vienna Nr. 1021/2017). Human milk was
centrifuged at 20,000 g for 10 min at 4 °C. One aliquot
was heated up to 85 °C for 1 h before freezing. For
cow’s milk, three different batches of pasteurized cow’s
milk (Billa Bergbauern Heumilch; Spar Halbfett Milch;
Hofer Milfina Halbfett Milch), yoghurt (Ja Natürlich
Naturjoghurt; Clever Joghurt; Nöm Naturjoghurt), sour
milk (Hofer Milfina Sauermilch; Nöm Sauermilch;
Schärdinger Sauermilch), buttermilk (Ja Natürlich
Buttermilch Natur; Clever Buttermilch; Spar free from
Buttermilch), and whey (Lattella Naturmolke; Clever
Fruchtmolke; Spar free from Molke) were pooled and
centrifuged, and then the aqueous fractions were stored
at − 20 °C until testing. For powdered milk, three differ-
ent batches (Aptamil, Milupa; Babylove, dm; Combiotik,
Hipp) were reconstituted and pooled prior to centrifuga-
tion. Samples were subjected to not more than two
freeze-thaw cycles.
Fig. 1 Human milk and cow’s milk suppress induced inflammation in
gingival fibroblasts. Gingival fibroblasts were exposed to a fresh-frozen
human milk, b pasteurized human milk, and c pasteurized cow’s milk
with and without IL-1 and TNFα. Data are indicated as a percent of gene
expression changes compared to control fibroblasts treated with
inflammatory factors. P values are indicated in the graphs
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Primary gingival fibroblasts and HSC2 cells
Human gingival fibroblasts were prepared from explant cul-
tures of three independent donors after approval of the Ethical
Committee of the Medical University of Vienna (EK Nr. 631/
2007). The epithelial cell line HSC2 was kindly provided by
Prof. Rausch-Fan, Department of Periodontology, Medical
University of Vienna, Vienna, Austria. Cells were cultured
in a humidified atmosphere at 37 °C in a growth medium
consisting of DMEM, 10% fetal calf serum, and 1% antibi-
otics (Invitrogen Corporation, Carlsbad, CA, USA). Cells
were plated in growthmedium at 30,000 cells/cm2 into culture
dishes. The following day, cells were exposed to 5% aqueous
fractions of the respective preparations for 1 h before adding
human IL-1β and TNFα (ProSpec-Tany TechnoGene Ltd.,
Rehovot, Israel), both at 5 ng/ml in growth medium. After
24 h, gene expression analysis was performed and supernatant
was collected for immunoassays.
qRT-PCR analysis and immunoassay
Total RNA was isolated with the ExtractMe total RNA kit
(Blirt S.A., Gdańsk, Poland). Reverse transcription was per-
formed with SensiFAST™ cDNA (Bioline, London, UK).
Polymerase chain reaction was done with the SensiFAST™
SYBR ROX Kit (Bioline) on a 7500 Real-Time PCR System
(both Applied Biosystems, Life Technologies Corporation,
Carlsbad, CA). Primer sequences are hIL1_F CTGATGGC
CCTAAACAGATGAAGT, hIL1_R AGCCCTTGCTGTAG
TGGTGGT; hIL6_F AATTCGGTACATCCTCGACGG,




The mRNA levels were calculated by normalizing to the
housekeeping gene GAPDH using the ΔΔCt method after
exponential expression transformation. For the immunoassay,
the human IL6 and IL8 Quantikine ELISA kit was used (R&D
Systems, Minneapolis, MN).
Statistical analysis
ANOVA testing comparing the mean rank of each treat-
ment group with the mean rank of the untreated control
group, followed by an uncorrected Fischer’s LSD post
hoc test, was performed. The P values are indicated in
the respective figures.
Results
Human milk and cow’s milk suppress induced
inflammation in gingival fibroblasts
The aqueous fractions of fresh-frozen human milk, pas-
teurized human milk, and pasteurized cow’s milk all
Table 1 Human milk and cow’s milk suppress induced IL6 production
in gingival fibroblasts. Gingival fibroblasts were exposed to fresh-frozen
human milk, pasteurized human milk, and pasteurized cow’s milk with
and without IL1 and TNFα. P values represent a paired t test compared to
the IL1/TNFα group. MM human milk, HMM pasteurized human milk,
CM pasteurized cow’s milk
wo IL1 + TNF MM MM+ IL1 + TNF HMM HMM+ IL1 + TNF CM CM+ IL1 + TNF
8 354 11 144 29 236 30 300
3 295 7 206 8 204 4 150
2 230 7 93 5 88 3 110
P = 0.04 P = 0.11 P = 0.19
Fig. 2 Fermented milk products reduce IL1-TNFα-induced
inflammation in gingival fibroblasts. Gingival fibroblasts were exposed
to aqueous fractions of a pooled yoghurt, b sour milk, c buttermilk, and d
wheywith andwithout IL1 and TNFα. Data indicate a percentage of gene
expression changes compared to control fibroblasts treated with
inflammatory factors. P values are indicated in the graphs
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lowered the inflammatory response of gingival fibro-
blasts exposed to IL1 and TNFα. The reduction in gene
expression was at least 40% in fibroblasts treated with
IL1 and TNFα (Fig. 1). Dose-response experiments in-
dicated that even 0.1% pasteurized human milk has an
anti-inflammatory effect on an in vitro model (data not
shown). Further support for the reduced inflammatory
response comes from immunoassays showing that IL6
and IL8 in the supernatant reduced inflammation when
gingival fibroblasts were exposed to 5% fresh-frozen
human milk, pasteurized human milk, and pasteurized
cow’s milk (Table 1). Together, these findings indicate
that milk induces an anti-inflammatory activity in an
in vitro setting when gingival fibroblasts are stimulated
with IL1 and TNFα.
Fermented milk products and powdered milk reduce
IL1-TNFα-induced inflammation in gingival
fibroblasts
Aqueous fractions of pooled yoghurt, sour milk, butter-
milk, and whey each reduced the inflammatory response
of gingival fibroblasts exposed to IL1 and TNFα. The
decrease in gene expression was at least 50% of the
positive control in gingival fibroblasts (Fig. 2).
Moreover, 5% powdered milk from three independent
manufacturers caused a substantial reduction of at least
70% in the inflammatory response of gingival fibroblasts
exposed to IL1 and TNFα (Fig. 3). Collectively, these
data suggest that not only fermented milk products but
also powdered milk maintain the anti-inflammatory activ-
ity of milk in a model using gingival fibroblasts.
Human milk and cow’s milk suppress
IL1-TNFα-induced inflammation in human epithelial
cells
When the human oral epithelial cell line HSC2 was ex-
posed to IL1 and TNFα, fresh-frozen human milk, pas-
teurized human milk, and pasteurized cow’s milk once
again lowered the inflammatory response. The reduction
in gene expression was at least 40% in the respective
positive control fibroblasts treated with IL1 and TNFα
(Fig. 4). Thus, the aqueous fractions of fresh-frozen
Fig. 3 Sprayed dried milk reduces IL1-TNFα-induced inflammation
in gingival fibroblasts. Gingival fibroblasts were exposed to
aqueous fractions of sprayed dried milk with and without IL1 and
TNFα. Data indicate a percentage of gene expression changes
compared to control fibroblasts treated with inflammatory factors.
P values are indicated in the graphs
Fig. 4 Human and cow’s milk suppress IL1-TNFα-induced inflammation
in human epithelial cells. HSC2 human epithelial cells were exposed to a
fresh-frozen human milk, b pasteurized human milk, and c pasteurized
cow’s milk with and without IL1 and TNFα. Data indicate a percentage
of gene expression changes compared to control fibroblasts treated with
inflammatory factors. P values are indicated in the graphs
Clin Oral Invest
human milk, pasteurized human milk, and pasteurized
cow’s milk also hold an anti-inflammatory potential in
oral epithelial cells.
Fermented milk products and powdered milk reduce
IL1-TNFα-induced inflammation in human epithelial
cells
As observed with gingival fibroblasts, a 5% aqueous
fraction of pooled yoghurt, sour milk, buttermilk, and
whey reduced the inflammatory response of the human
epithelial cell line HSC2 exposed to IL1 and TNFα. The
reduction in expression of inflammatory genes was at
least 30% in the HSC2 cells treated with IL1 and
TNFα (Fig. 5). Likewise, powdered milk from three
companies caused a significant decrease of at least 30%
in the inflammatory response of HSC2 cells exposed to
IL1 and TNFα (Fig. 6). These observations suggest that
fermented milk products as well as powdered milk have
an anti-inflammatory activity in vitro when using human
epithelial cells (Table 2).
Discussion
Oral mucositis is a critical issue in patients exposed to
radiation [19] and/or chemotherapy [20], and in those
with chronic inflammatory disorders such as Crohn’s dis-
ease [21], periodontitis, and peri-implantitis. Today’s
anti-inflammatory strategies include antibiotics, as well
as oral mouth rinses supplemented with chlorhexidine
[22] and other pharmacological compounds [23]. These
potent therapies, however, have side effects and should
be restricted to a limited time period [24]. Consequently,
there is a growing demand for anti-inflammatory strate-
gies to complement the range of traditional pharmacolog-
ical therapies. These are based on natural components
such as propolis [25], green tea [26], and aloe vera
[27]. The possible anti-inflammatory effect of milk and
related products for the oral cavity has not been consid-
ered so far, even though there is strong evidence that
milk can reduce inflammation of the intestine [1, 2].
The main finding of the present study was that pasteur-
ized human milk and pasteurized cow’s milk, as well as
also yoghurt, buttermilk, sour milk, whey, and dry milk
reduce the inflammatory response of gingival fibroblasts
and oral epithelial cells exposed to IL1 and TNFα.
Questions arising are related to the ranking of the
tested compounds. In this way, a clinician would have
Fig. 5 Fermented milk products reduce IL1-TNFα-induced
inflammation in human epithelial cells. HSC2 human epithelial cells were
exposed to aqueous fractions of a pooled yoghurt, b sour milk, c
buttermilk, and d whey with and without IL1 and TNFα. Data indicate
a percent of gene expression changes compared to control fibroblasts
treated with inflammatory factors. P values are indicated in the graphs
Fig. 6 Powdered milk products reduce IL1-TNFα-induced
inflammation in human epithelial cells. HSC2 human epithelial
cells were exposed to aqueous fractions of powdered milk with
and without IL1 and TNFα. Data indicate a percent of gene
expression changes compared to control fibroblasts treated with
inflammatory factors. P values are indicated in the graphs
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a better idea which dairy products were most effective at
lowering inflammation The present study, however, was
exploratory, meaning that it was not our intension to
compare the anti-inflammatory activity of the various
preparations; hence, the study is underpowered for this
purpose and the variation between the experiments was
rather high, likely because of the variation caused by the
primary cells and variations between the different batches
within one group. Nevertheless, we did a nonparametric
comparison of all seven groups and failed to reach the
level of significance. Hence, it requires a more controlled
setting to determine possible differences in the anti-
inflammatory activity of the groups investigated.
If we relate these findings to those of other re-
searchers, the results are consistent with observations in
different in vitro systems. For example, pre-term human
milk suppresses TNF-induced inflammation in intestinal
epithelial cells [4]. All other in vitro studies focus on
fractions of milk such as hydrolysate to reduce the in-
flammatory response of TNFα-challenged colon cancer
cells and LPS-challenged porcine colonic explants [5].
Moreover, whey protein hydrolysates decrease IL8 secre-
tion in LPS-stimulated respiratory epithelial cells [6].
Thus, there is moderate knowledge of the in vitro anti-
inflammatory activity of milk and related products, even
though there is strong evidence from pre-clinical research
and clinical studies that milk prevents enterocolitis [1].
The present in vitro research therefore advances current
knowledge based on intestinal epithelial cells, adding
further support for the anti-inflammatory activity of milk
and related products in oral gingival fibroblasts and a
human oral epithelial cell line.
The underlying molecular mechanism responsible for the
anti-inflammatory effect of milk and its respective products
remains open. Considering that casein and whey hydrolysates
display an anti-inflammatory effect on colon and respiratory
epithelial cells [5, 6], together with our findings based on
fermented milk products and even powdered milk (the latter
being heated up to 160 °C) [11], it is likely that a milk com-
ponent which resists heating and fermentation is responsible
for the anti-inflammatory activity in the various cell types.
Soluble TNFα receptors IL1Ra neutralizing the bioactivity
of the respective cytokines [28, 29] are present in milk but
are presumably not that heat stable to exert the anti-
inflammatory activity of powdered milk.
Human milk oligosaccharides have an anti-inflammatory
effect and are resistant to pasteurization and freeze-drying
[30]. They are highly abundant in milk besides lactose, fat,
and proteins. There is an existing hypothesis that milk oligo-
saccharides reduce the risk of necrotizing enterocolitis in pre-
mature infants [31, 32]. Moreover, milk oligosaccharides can
suppress inflammation in colonic epithelial cells [33] and
trinitrobenzenesulfonic acid-induced colitis in rats [34]. Milk
oligosaccharides also reduce E. coli-induced interleukin IL8
release by intestinal epithelial cells [35]. It is likely that milk
and its respective products exert their anti-inflammatory effect
possibly independent of the target cell for IL1 and TNFα.
What also remains to be clarified in future research is whether
milk neutralizes IL1 and TNFα, and consequently prevents
the binding to the respective receptors, or if it activates the
anti-inflammatory mechanism that suppresses activation of
the inflammosome [36].
The clinical relevance of the present data remains at the
level of speculation. Even though in vitro, milk, fermented
milk products, and powdered milk possess a potent anti-
inflammatory effect, as to whether this observation can be
applied to patients suffering from oral mucositis is question-
able. Epidemiological research into the association between
the intake of yoghurt and the incidence of periodontitis, in a
nationally representative sample of Korean adults, conflicts
with this proposition [37]. Recent systematic reviews on the
protective effect of breastfeeding with respect to malocclusion
and caries raise a possible role of milk in oral health, but not
with a focus on inflammation [38]. Again, the pre-clinical and
the clinical data supporting milk in preventing enterocolitis
only serve as a basis for a hypothesis on the possible anti-
inflammatory activity of milk in the oral cavity.
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